Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription 27.05.2024 2 Acta Neuropathol 4 Alzheimers Dement 1 Ann Neurol 1 BMC Geriatr 1 BMJ 2 Br J Psychiatry 2 Brain Res 1 Curr Alzheimer Res 2 Exp Neurol 8 J Alzheimers Dis 3 Neurobiol Aging 1 Neurobiol Dis 1 Neurochem Res 2 Neurology 1 Neurosci Lett 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. ELLIS MJ, Lekka C, Holden KL, Tulmin H, et al
   Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry.
   Acta Neuropathol. 2024;147:87.
   PubMed         Abstract available
   
   
2. THIERRY M, Ponce J, Marta-Ariza M, Askenazi M, et al
   The influence of APOE(epsilon4) on the pTau interactome in sporadic Alzheimer's disease.
   Acta Neuropathol. 2024;147:91.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

3. GARCIA RATES S, Garcia-Ayllon MS, Falgas N, Brangman SA, et al
   Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid.
   Alzheimers Dement. 2024 May 23. doi: 10.1002/alz.13869.
   PubMed         Abstract available
   
   
4. LATIF-HERNANDEZ A, Yang T, Raymond-Butler R 3rd, Losada PM, et al
   A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model.
   Alzheimers Dement. 2024 May 23. doi: 10.1002/alz.13857.
   PubMed         Abstract available
   
   
5. TOSUN D, Hausle Z, Iwaki H, Thropp P, et al
   A cross-sectional study of alpha-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.
   Alzheimers Dement. 2024 May 21. doi: 10.1002/alz.13858.
   PubMed         Abstract available
   
   
6. MOGUILNER SG, Berezuk C, Bender AC, Pellerin KR, et al
   Sleep functional connectivity, hyperexcitability, and cognition in Alzheimer's disease.
   Alzheimers Dement. 2024 May 19. doi: 10.1002/alz.13861.
   PubMed         Abstract available
   
   

   
   Ann Neurol

7. DICARLO M, Pignataro P, Zecca C, Dell'Abate MT, et al
   Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease.
   Ann Neurol. 2024 May 23. doi: 10.1002/ana.26946.
   PubMed         Abstract available
   
   

   
   BMC Geriatr

8. ZHU Y, Zhu F, Guo X, Huang S, et al
   Appendicular lean mass and the risk of stroke and Alzheimer's disease: a mendelian randomization study.
   BMC Geriatr. 2024;24:438.
   PubMed         Abstract available
   
   

   
   BMJ

9. NOLAN T
   A potential new treatment for Alzheimer's disease ... and other research.
   BMJ. 2024;385:q1125.
   PubMed        
   
   

   
   Br J Psychiatry

10. BELL G, El Baou C, Saunders R, Buckman JEJ, et al
    Predictors of primary care psychological therapy outcomes for depression and anxiety in people living with dementia: evidence from national healthcare records in England.
    Br J Psychiatry. 2024;224:205-212.
    PubMed         Abstract available
    
    
11. HAMILTON CA, Matthews FE, Attems J, Donaghy PC, et al
    Associations between multimorbidity and neuropathology in dementia: consideration of functional cognitive disorders, psychiatric illness and dementia mimics.
    Br J Psychiatry. 2024;224:237-244.
    PubMed         Abstract available
    
    

    
    Brain Res

12. ZHOU Q, Xu L
    The regulation of BAI1 in astrocytes through the STAT3/EZH2 axis relieves neuronal apoptosis in rats with Alzheimer's disease.
    Brain Res. 2024;1839:149007.
    PubMed         Abstract available
    
    
13. BHADANE P, Roul K, Belemkar S, Kumar D, et al
    Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress.
    Brain Res. 2024 May 21:149018. doi: 10.1016/j.brainres.2024.149018.
    PubMed         Abstract available
    
    

    
    Curr Alzheimer Res

14. ALHARBI KM, Alshehri SA, Almarwani WA, Aljohani KK, et al
    Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis.
    Curr Alzheimer Res. 2024 May 17. doi: 10.2174/0115672050315334240508162754.
    PubMed         Abstract available
    
    

    
    Exp Neurol

15. ZHANG Y, Mu BR, Ran Z, Zhu T, et al
    Pericytes in Alzheimer's disease: Key players and therapeutic targets.
    Exp Neurol. 2024 May 20:114825. doi: 10.1016/j.expneurol.2024.114825.
    PubMed         Abstract available
    
    
16. EL-ARABY RE, Wasif K, Johnson R, Tu Q, et al
    Establishment of a novel cellular model for Alzheimer's disease in vitro studies.
    Exp Neurol. 2024 May 22:114820. doi: 10.1016/j.expneurol.2024.114820.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

17. HERMES S, Cady J, Armentrout S, O'Connor J, et al
    Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-230236.
    PubMed         Abstract available
    
    
18. CHAI YL, Strohm L, Zhu Y, Chia RSL, et al
    Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-230572.
    PubMed         Abstract available
    
    
19. DUCHESNE S, Rousseau LS, Belzile-Marsolais F, Welch LA, et al
    A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories.
    J Alzheimers Dis. 2024 May 24. doi: 10.3233/JAD-230772.
    PubMed         Abstract available
    
    
20. GAMM S, Ummel D, Vasil N, Grenier S, et al
    Getting Insight to the Lived Emotional Experience of People with Alzheimer's Disease Shortly After Diagnosis: A Phenomenological Approach.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-231403.
    PubMed         Abstract available
    
    
21. AGUILAR BJ, Jasuja GK, Li X, Shishova E, et al
    Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
    J Alzheimers Dis. 2024 May 23. doi: 10.3233/JAD-240027.
    PubMed         Abstract available
    
    
22. NING M, An L, Dong L, Zhu R, et al
    Causal Associations Between Gut Microbiota, Gut Microbiota-Derived Metabolites, and Alzheimer's Disease: A Multivariable Mendelian Randomization Study.
    J Alzheimers Dis. 2024 May 20. doi: 10.3233/JAD-240082.
    PubMed         Abstract available
    
    
23. STARMANS NLP, Kappelle LJ, Muller M, Staals J, et al
    Blood Pressure Variability and Plasma Biomarkers of Neuronal Injury and Alzheimer's Disease: A Clinic-Based Study of Patients with Diseases Along the Heart-Brain Axis.
    J Alzheimers Dis. 2024 May 21. doi: 10.3233/JAD-240119.
    PubMed         Abstract available
    
    
24. PRZYBYSZEWSKI AW, Chudzik A
    How to Cure Alzheimer's Disease.
    J Alzheimers Dis. 2024 May 18. doi: 10.3233/JAD-240231.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

25. LIU R, Li JZ, Song JK, Zhou D, et al
    Corrigendum to: "Pinocembrin improves cognition and protects the neurovascular unit in Alzheimer related deficits" [Neurobiol. Aging 35 (2014) 1275-1285].
    Neurobiol Aging. 2024 May 22:S0197-4580(24)00101.
    PubMed        
    
    
26. YANG Q, Zhou X, Ma T
    Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease.
    Neurobiol Aging. 2024;140:116-121.
    PubMed         Abstract available
    
    
27. WINFREE RL, Erreger K, Phillips J, Seto M, et al
    Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline.
    Neurobiol Aging. 2024;140:93-101.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

28. PAIVA I, Seguin J, Grgurina I, Singh AK, et al
    Dysregulated expression of cholesterol biosynthetic genes in Alzheimer's disease alters epigenomic signatures of hippocampal neurons.
    Neurobiol Dis. 2024 May 22:106538. doi: 10.1016/j.nbd.2024.106538.
    PubMed         Abstract available
    
    

    
    Neurochem Res

29. QIU NZ, Hou HM, Guo TY, Lv YL, et al
    Phosphodiesterase 8 (PDE8): Distribution and Cellular Expression and Association with Alzheimer's Disease.
    Neurochem Res. 2024 May 23. doi: 10.1007/s11064-024-04156.
    PubMed         Abstract available
    
    

    
    Neurology

30. DUBINSKY RM, Stein AC
    Predicting Driving Cessation in Alzheimer Disease: Performance Beats Biomarkers.
    Neurology. 2024;102:e209523.
    PubMed        
    
    
31. BABULAL GM, Chen L, Murphy SA, Carr DB, et al
    Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments.
    Neurology. 2024;102:e209426.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

32. FAZELINEJAD H, Zahedi E, Khadivi M
    Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights into the therapeutic role of Bis (Indolyl) phenylmethane.
    Neurosci Lett. 2024;833:137825.
    PubMed         Abstract available
    
    

    
    PLoS One

33. HASSANZADEH R, Abrol A, Pearlson G, Turner JA, et al
    A confounder controlled machine learning approach: Group analysis and classification of schizophrenia and Alzheimer's disease using resting-state functional network connectivity.
    PLoS One. 2024;19:e0293053.
    PubMed         Abstract available
    
    
34. RHODIUS-MEESTER HFM, van Maurik IS, Collij LE, van Gils AM, et al
    Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.
    PLoS One. 2024;19:e0303111.
    PubMed         Abstract available
    
    
35. SONG B, Yoshida S
    Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
    PLoS One. 2024;19:e0303278.
    PubMed         Abstract available
    
    
36. NADKARNI R, Han ZY, Anderson RJ, Allphin AJ, et al
    High-resolution hybrid micro-CT imaging pipeline for mouse brain region segmentation and volumetric morphometry.
    PLoS One. 2024;19:e0303288.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

37. TURNER GR, Hewan P, Wearn A, van Dooren R, et al
    Locus coeruleus integrity is related to an exploitation-based decision-making bias in older adulthood.
    Proc Natl Acad Sci U S A. 2024;121:e2322617121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.